Kissei Pharmaceutical Co., Ltd.
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Public
- Established
- 1946-08-09
- Employees
- 1.7K
- Market Cap
- -
- Website
- http://www.kissei.co.jp
A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2023-12-21
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT04132050
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
Phase 3
Completed
- Conditions
- Endometriosis
- Interventions
- Drug: Add-back capsule (E2 1 mg / NETA 0.5 mg)Drug: Placebo capsule to match Add-back capsule
- First Posted Date
- 2019-06-20
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 486
- Registration Number
- NCT03992846
- Locations
- 🇺🇸
Wellington Anti-Aging, LLC/ ID # 613, Loxahatchee Groves, Florida, United States
🇦🇹AKH Vienna University of Medicine Vienna / ID # 101, Vienna, Austria
🇨🇿MUDr Jan Drahonovsky, Ustav pro peci o matku a dite/ ID #163, Praha 4, Czechia
A Phase 3 Study to Confirm the Efficacy and Safety of Linzagolix to Treat Endometriosis-associated Pain
Phase 3
Terminated
- Conditions
- Endometriosis
- Interventions
- Drug: Add-back capsule (E2 1 mg / NETA 0.5 mg)Drug: Placebo capsule to match Add-back capsule
- First Posted Date
- 2019-06-14
- Last Posted Date
- 2025-04-02
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 85
- Registration Number
- NCT03986944
- Locations
- 🇺🇸
CMEP/CMU health / ID # 812, Saginaw, Michigan, United States
🇺🇸Center for Women's Health / ID # 761, Greenwood Village, Colorado, United States
🇺🇸Physicians Research Options, LLC / Red Rocks Ob/Gyn / ID # 732, Lakewood, Colorado, United States
A Clinical Study of KDT-3594 in Patients With Early Parkinson's Disease.
- First Posted Date
- 2019-02-19
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 74
- Registration Number
- NCT03845387
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
A Clinical Study of MR13A9 in Hemodialysis Patients With Pruritus.
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2021-02-17
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 247
- Registration Number
- NCT03802617
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
- First Posted Date
- 2017-06-06
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT03177668
- Locations
- 🇯🇵
Research Site, Multiple Locations, Japan
Clinical Study of KDT-3594 in Healthy Adult Males and Patients With Parkinson's Disease
- First Posted Date
- 2017-03-01
- Last Posted Date
- 2019-04-01
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 36
- Registration Number
- NCT03068481
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02912494
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
- First Posted Date
- 2016-09-23
- Last Posted Date
- 2019-04-02
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Registration Number
- NCT02912533
An Additional Confirmatory Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)
- First Posted Date
- 2016-09-05
- Last Posted Date
- 2018-12-14
- Lead Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Target Recruit Count
- 203
- Registration Number
- NCT02889302
© Copyright 2025. All Rights Reserved by MedPath